A new sort of anticancer drug, designed to suppress the wayward protein that causes a type of leukaemia, is under the spotlight. Biological detective work has now revealed how this cancer becomes resistant to the drug.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Druker, B. J. et al. New Engl. J. Med. 344, 1031–1037 (2001).
Druker, B. J. et al. New Engl. J. Med. 344, 1038–1042 (2001).
Gorre, M. E. et al. Science 21 June 2001 (10.1126/science.1062538).
Konopka, J. B., Watanabe, S. M. & Witte, O. N. Cell 37, 1035–1042 (1984).
McCormick, F. Curr. Opin. Biotechnol. 11, 593–597 (2000).
Allegra, C. & Grem, J. L. in Cancer: Principles and Practice of Oncology (eds DeVita, V. T., Hellman, S. & Rosenberg, S. A.) 432–448 (Lippincott-Raven, Philadelphia, 1997).
Melnick, A. & Licht, J. D. Blood 93, 3167–3215 (1999).
Huang, M. E. et al. Blood 72, 567–572 (1988).
Gambacorti-Passerini, C. et al. Br. J. Haematol. 112, 972–974 (2001).
Gray, J. W. & Collins, C. Carcinogenesis 21, 443–452 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McCormick, F. New-age drug meets resistance. Nature 412, 281–282 (2001). https://doi.org/10.1038/35085665
Issue Date:
DOI: https://doi.org/10.1038/35085665
This article is cited by
-
The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib
Investigational New Drugs (2009)
-
An HSV-2-based oncolytic virus deleted in the PK domain of the ICP10 gene is a potent inducer of apoptotic death in tumor cells
Gene Therapy (2007)
-
Escape from inhibition
Nature (2003)
-
STI-571 must select for drug-resistant cells but ‘no cell breathes fire out of its nostrils like a dragon’
Leukemia (2002)
-
Cancer gene therapy: fringe or cutting edge?
Nature Reviews Cancer (2001)
